On Thursday, Bluebird Bio Inc. (NASDAQ:BLUE) reported a third-quarter EPS loss of 31 cents, compared to a loss of 80 cents a ...

expanding the tokenized asset industry will need more traditional investors which, in turn, are demanding more ...

These things, coupled with strong revenue growth, good profitability, a sound balance sheet and a market cap of $3.5 trillion ...

On Thursday, Viasat Inc (VSAT) stock saw a decline, ending the day at $7.73 which represents a decrease of $-0.17 or -2.15% from the prior close of $7.9. The stock opened at $7.85 and touched a low of ...

With 2025 on the horizon, investors are sharpening their focus on the year ahead, selecting portfolio additions that aim to bring solid ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 8.96% of ...

J.P. Morgan Chase is focused on supporting the growth of companies along the Front Range of the Rockies by advising on ...

J.P. Morgan is targeting tech startups as clients after Silicon Valley Bank, First Republic Bank and Silvergate Bank ...

Jake Paul and Mike Tyson aren’t the only ones who have high stakes when they meet in the boxing ring on Friday night ...

Investor preferences seem to have shifted from gold to equities amid confidence in the President-elect's economic policies.

JP Morgan initiated coverage on Blueprint Medicines Corporation (NASDAQ:BPMC), a biotech company focused on modulating immune ...

In a report released today, Andrew Wilson CFA from J.P. Morgan maintained a Buy rating on Siemens (0P6M – Research Report), with a price ...